East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Budesonide + Formoterol
Symbicort SMART
Not routinely available
SMC (1244/17)
29/03/2023

Indication

The regular treatment of asthma where use of a combination (inhaled corticosteroid and a long-acting β2 adrenoceptor agonist is appropriate: patients not adequately controlled with inhaled corticosteroids and "as needed" short-acting β2 adrenoceptor agonists, or patients already adequately controlle...

The regular treatment of asthma where use of a combination (inhaled corticosteroid and a long-acting β2 adrenoceptor agonist is appropriate: patients not adequately controlled with inhaled corticosteroids and "as needed" short-acting β2 adrenoceptor agonists, or patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.

Therapeutic Area

Respiratory system

Status Description

Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines

Formulation

100 micrograms/6 micrograms and 200 micrograms/6 micrograms inhalation powder

Comments

-

Link to Advice

1244/17

Advice Published

12/06/2017

SMC Submission Type

Abbreviated

SMC Status

Accepted